SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-24-000075
Filing Date
2024-06-10
Accepted
2024-06-10 16:40:12
Documents
1
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718052003.html 4  
1 FORM 4 wk-form4_1718052003.xml 4 3907
  Complete submission text file 0001576885-24-000075.txt   5369
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 241033343

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)